SUBSCRIBE
SUBSCRIBE

Vor Bio

NEWS
Business
Movers & Shakers: CEO Shakeups at BIO, Passage Bio and Palisade Bio
The Biotechnology Innovation Organization, Passage Bio and Palisade Bio saw leadership shakeups at the top, while Maze Therapeutics, Cerecin and more appointed new chief medical officers.
October 13, 2022
 · 
4 min read
 · 
Alex Keown
Astellas Pharma, Proteostasis Therapeutics Forge $1.2 Billion Genetic Disease Drug Development Pact
Business
Hours After Debuting Biotech Startup Vor BioPharma, PureTech Launches Alivio Therapeutics
May 10, 2016
 · 
3 min read
Business
Pulitzer Prize Author of “Emperor of All Maladies” Launches Biotech Startup Vor BioPharma in Boston
May 9, 2016
 · 
3 min read
JOBS
IN THE PRESS
Press Releases
Vor Bio Appoints Seasoned Healthcare Institutional Investor, Han Choi, M.D., LL.M., as Chief Financial Officer
September 30, 2024
 · 
5 min read
Drug Development
New Clinical Data Validates Vor Bio’s Approach of Using Shielded Transplants to Deliver Targeted Therapies
September 5, 2024
 · 
6 min read
Press Releases
Vor Bio to Participate in Upcoming Investor Conferences
August 30, 2024
 · 
1 min read
Press Releases
Vor Bio Reports Second Quarter 2024 Financial Results and Provides Company Update
August 9, 2024
 · 
6 min read
Business
Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - July 09, 2024
July 10, 2024
 · 
1 min read
Genetown
Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - June 04, 2024
June 4, 2024
 · 
1 min read
Business
Vor Bio Reports First Quarter 2024 Financial Results and Provides Company Update
May 9, 2024
 · 
6 min read
Genetown
Vor Bio to Participate in Upcoming May 2024 Investor Conferences
May 6, 2024
 · 
1 min read
Genetown
Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - May 03, 2024
May 3, 2024
 · 
1 min read
Business
Vor Bio Appoints Accomplished Oncology and Cancer Immunotherapy R&D Executive, Fouad Namouni, M.D., to its Board of Directors
May 2, 2024
 · 
4 min read
Load More